[German Cancer Society e.V. S3 guideline for PSA determination in diagnosis of prostatic carcinoma].
Rübben
H
H
Deutsche Gesellschaft für Urologie, Deutsche Krebsgesellschaft e. V., Frankfurt. service@krebsgesellschaft.de
Schalkhäuser
K
K
Wolff
J
J
Luboldt
H-J
HJ
D014408:Biomarkers, Tumor / Q000097:blood*; D005858:Germany; D006801:Humans; D008297:Male; D008403:Mass Screening; D011230:Precancerous Conditions / Q000097:blood / Q000175:diagnosis*; D011237:Predictive Value of Tests; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis*
D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen